Broad cytotoxic targeting of acute myeloid leukemia by highly polyclonal Delta One T cells
暂无分享,去创建一个
T. Carvalho | M. G. Silva | I. Prinz | B. Silva-Santos | Francisco Caiado | H. Norell | D. Vermijlen | A. Simões | Paola Tieppo | D. V. Correia | Haakan Norell | Sarina Ravens | Biagio Di Lorenzo | T. Schumacher | -. JulieDéchanet | Merville
[1] S. Tasian. Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled? , 2018, Therapeutic advances in hematology.
[2] B. Silva-Santos,et al. Molecular Determinants of Target Cell Recognition by Human γδ T Cells , 2018, Front. Immunol..
[3] Omkar U. Kawalekar,et al. CAR T cell immunotherapy for human cancer , 2018, Science.
[4] Yupo Ma,et al. Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia , 2018, Leukemia.
[5] G. Graça,et al. VEGFR2-Mediated Reprogramming of Mitochondrial Metabolism Regulates the Sensitivity of Acute Myeloid Leukemia to Chemotherapy. , 2018, Cancer research.
[6] A. Wei,et al. Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML. , 2017, Blood.
[7] J. Gribben,et al. The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia , 2017, Nature Communications.
[8] R. Geffers,et al. Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection , 2017, Nature Immunology.
[9] D. Chudakov,et al. Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance , 2017, Nature Communications.
[10] Y. Saeys,et al. The checkpoint for agonist selection precedes conventional selection in human thymus , 2016, Science Immunology.
[11] C. L. da Silva,et al. Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept , 2016, Clinical Cancer Research.
[12] M. Carroll,et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. , 2014, Blood.
[13] Xiuli Wang,et al. T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia. , 2013, Blood.
[14] T. Schumacher,et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors , 2013, Nature.
[15] B. Silva-Santos,et al. Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. , 2011, Blood.
[16] J. Mehta,et al. Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation , 2007, Bone Marrow Transplantation.